Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01467310
Title Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Trametinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.